Norway

Norway country outline

Estimated Number of Current PrEP Users

600-800

Aggregate Target Number of PrEP Users from All Projects (Planned and Ongoing)

N/A

Types of Delivery Projects

National level

*Definitions of types of projects available in the glossary below.

Drug Registration Status

  • Gilead’s Truvada (TDF/FTC) is registered and approved for prevention
  • Generic versions of TDF/FTC are approved for prevention

Funding

Not available


Eligibility Criteria
Resources for Norway
Glossary of Terms

Last updated April 16, 2018.

News Spotlight